<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02619955</url>
  </required_header>
  <id_info>
    <org_study_id>35RC14_9841</org_study_id>
    <nct_id>NCT02619955</nct_id>
  </id_info>
  <brief_title>Cohort of Patients With Rare Iron Overloads Excluding C282Y Homozygosity</brief_title>
  <acronym>HEPCICOR</acronym>
  <official_title>Hepcicor Cohort : Clinical, Biological, Genetic and Fonctional charactérization of Rare Iron Overlaod phénotypes Associated With Hepcidin Deficiency Excluding C282Y Homozygosity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study explores the hepcidin deficiency causes of rare iron overload (excluding C282Y
      homozygosity), and aim to characterize this iron overload in term of clinical, biological,
      genetic and functional spacificities.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic iron overload are responsible for morbidity and mortality. There are many causes,
      genetic and acquired. Hepcidin deficiency related to genetic desease is one of them.

      This study concerns specifically this cause, and seeks to characterize these iron overloads
      on clinical, biological, genetic and functional point of view.

      A significant number of patients with chronic iron overload, present a phenotype of hepcidin
      deficiency. This profile is characterized by an elevated plasma iron increased serum
      transferrin saturation, a transferrin saturation, and a parenchyma distribution of iron
      overload. These diseases either remains unexplained or are associated with mutations in the
      gene involved in iron metablism regulation.

      The main objective of this study is to characterize these iron overloads with phenotype of
      hepcidin deficiency not related to homozygosity C282Y (clinical, biological and genetic).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients presenting with mutation in gene know to be associated with iron metabolism</measure>
    <time_frame>Inclusion</time_frame>
    <description>to characterize these iron overloads with phenotype of hepcidin deficiency not related to homozygosity C282Y (clinical, biological and genetic).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>comparison of the hepcidin and hepcidin/ferritin ratio in patient with or without in gene known to be associated with iron metabolism</measure>
    <time_frame>inclusion</time_frame>
    <description>To Identificate potential explanatory factors of hepcidino deficiency phenotype</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients presenting with associated causes of iron overload</measure>
    <time_frame>inclusion</time_frame>
    <description>- Identification of potentially explanatory factors visceral consequences of iron overload in hepcidino deficiency phenotype (overweight, high blood pressure, diabetes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Genotype-Phenotype correlation</measure>
    <time_frame>Inclusion</time_frame>
    <description>To Research correlations genotype-phenotype</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hepatic and splenic iron concentration measurements by NMR</measure>
    <time_frame>Inclusion</time_frame>
    <description>Validation of the hepatic iron concentration measurements imaging ( nuclear magnetic resonance (NMR)) in the various centers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with detectable abnormal iron species in blood (non transferrin bound iron, labile pool iron)</measure>
    <time_frame>Inclusion</time_frame>
    <description>- Assessment of the clinical value of biomarkers of iron metabolism</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Rare Iron Overlaods</condition>
  <arm_group>
    <arm_group_label>Rare iron overload with hepcidin deficiency</arm_group_label>
    <description>clinical, biological, and genetic analysis of rare iron overlaod phenotype (except C282Yhomozygisity), samples with DNA</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>samples with DNA</intervention_name>
    <arm_group_label>Rare iron overload with hepcidin deficiency</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting a rare iron overloads with hepcidin deficiency
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Biological profile suggestive of hepcidin deficiency:

               -  increase of transferrin saturation coefficient (&gt; 50 %) verified on at least 2
                  times, and calculated from the transferrinemia.

               -  Proved hepatic iron overload: by the dosage of the iron hepatic concentration
                  either on block hepatic biopsic, or by MRI according to the method of
                  quantification of the iron validated overload (by adopting a threshold of 100
                  µmol /g)

               -  Patient's written consent for examination of genetic characteristics for
                  diagnosis and collection development for genetic and not genetic research within
                  the framework of an abnormality of the iron metabolism

               -  Patient written inform consent.

        Exclusion Criteria:

          -  HFE hemochromatosis: homozygosity C282Y/C282Y

          -  Treatment with iterative phlebotomy

          -  Hematologic diseases with dyserythropoiesis and/or repeated transfusions

          -  Haptoglobin low, below normal directing towards the diagnosis of chronic hemolysis,
             myelodysplasia

          -  Prolonged oral or parenteral iron supplementation

          -  Current or past excessive regular drinking

          -  Patient minor or under legal protection measure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edouard BARDOU-JACQUET, MD/PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Pontchaillou</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Edouard BARDOU-JACQUET, MD/PhD</last_name>
    <phone>2 99 28 53 08</phone>
    <phone_ext>0033</phone_ext>
    <email>edouard.bardou-jacquet@chu-rennes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Limoges - Médecine interne A</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Véronique Loustaud-Ratti, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Lyon-Sud</name>
      <address>
        <city>Lyon</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stéphane DURUPT</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU de Montpellier - Hôpital St Eloi</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patricia Aguilar-Martinez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Hasenrain</name>
      <address>
        <city>Mulhouse</city>
        <zip>68051</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robert BADER</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital E.Muller</name>
      <address>
        <city>Mulhouse</city>
        <zip>68070</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bernard DRENOU</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHR La Source</name>
      <address>
        <city>Orléans</city>
        <zip>45067</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Causse Xavier, MD</last_name>
      <phone>+33-238-229-658</phone>
      <email>xavier.causse@chr-orleans.fr</email>
    </contact>
    <investigator>
      <last_name>Causse Xavier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bardou Jacquet</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edouard Bardou-Jacquet, MD/PHD</last_name>
      <email>edouard.bardou-jacquet@chu-rennes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Purpan</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christophe BUREAU, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Paul Brousse</name>
      <address>
        <city>Villejuif</city>
        <zip>94804</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>PELLETIER Gilles</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2015</study_first_submitted>
  <study_first_submitted_qc>November 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2015</study_first_posted>
  <last_update_submitted>September 9, 2016</last_update_submitted>
  <last_update_submitted_qc>September 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hepcidin deficiency</keyword>
  <keyword>genetic</keyword>
  <keyword>except C282Y Homozygosity</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepcidins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

